Company profile ADMA
After 38 days of this quarter the interest is at 54.0. Based on that we can calculate that during remaining 53 days it will total up to 129.0. ADMA Biologics expected interest is significantly higher compared to previous quarter (+59.3%) and same quarter last year (+46.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 101 | 139 37.6% QoQ | 111 -20.1% QoQ | 135 21.6% QoQ |
| 2020 | 94 -6.9% YoY -30.4% QoQ | 181 30.2% YoY 92.6% QoQ | 433 290.1% YoY 139.2% QoQ | 217 60.7% YoY -49.9% QoQ |
| 2021 | 177 88.3% YoY -18.4% QoQ | 166 -8.3% YoY -6.2% QoQ | 89 -79.4% YoY -46.4% QoQ | 151 -30.4% YoY 69.7% QoQ |
| 2022 | 99 -44.1% YoY -34.4% QoQ | 137 -17.5% YoY 38.4% QoQ | 71 -20.2% YoY -48.2% QoQ | 119 -21.2% YoY 67.6% QoQ |
| 2023 | 88 -11.1% YoY -26.1% QoQ | 104 -24.1% YoY 18.2% QoQ | 97 36.6% YoY -6.7% QoQ | 81 -31.9% YoY -16.5% QoQ |
| 2024 | 54 -38.6% YoY -33.3% QoQ | - | - | - |
The average 5 years interest of ADMA Biologics was 10.94 per week. The last year interest of ADMA Biologics compared to the last 5 years has changed by -33.55%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -28.8%.
After 38 days of this quarter the interest is at 16.0. Based on that we can calculate that during remaining 53 days it will total up to 38.0. ADMA Biologics stock expected interest is significantly lower compared to previous quarter (-61.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 187 | 133 -28.9% QoQ | 0 -100.0% QoQ | 52 inf% QoQ |
| 2020 | 54 -71.1% YoY 3.8% QoQ | 125 -6.0% YoY 131.5% QoQ | 386 inf% YoY 208.8% QoQ | 239 359.6% YoY -38.1% QoQ |
| 2021 | 180 233.3% YoY -24.7% QoQ | 67 -46.4% YoY -62.8% QoQ | 152 -60.6% YoY 126.9% QoQ | 83 -65.3% YoY -45.4% QoQ |
| 2022 | 58 -67.8% YoY -30.1% QoQ | 16 -76.1% YoY -72.4% QoQ | 129 -15.1% YoY 706.2% QoQ | 88 6.0% YoY -31.8% QoQ |
| 2023 | 49 -15.5% YoY -44.3% QoQ | 73 356.2% YoY 49.0% QoQ | 57 -55.8% YoY -21.9% QoQ | 98 11.4% YoY 71.9% QoQ |
| 2024 | 16 -67.3% YoY -83.7% QoQ | - | - | - |
The average 5 years interest of ADMA Biologics stock was 8.62 per week. The last year interest of ADMA Biologics stock compared to the last 5 years has changed by -38.86%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -29.55%.
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. ADMA Biologics news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 0 | 81 inf% QoQ | 61 -24.7% QoQ |
| 2020 | 18 inf% YoY -70.5% QoQ | 49 inf% YoY 172.2% QoQ | 103 27.2% YoY 110.2% QoQ | 62 1.6% YoY -39.8% QoQ |
| 2021 | 146 711.1% YoY 135.5% QoQ | 116 136.7% YoY -20.5% QoQ | 71 -31.1% YoY -38.8% QoQ | 101 62.9% YoY 42.3% QoQ |
| 2022 | 38 -74.0% YoY -62.4% QoQ | 31 -73.3% YoY -18.4% QoQ | 118 66.2% YoY 280.6% QoQ | 132 30.7% YoY 11.9% QoQ |
| 2023 | 54 42.1% YoY -59.1% QoQ | 56 80.6% YoY 3.7% QoQ | 100 -15.3% YoY 78.6% QoQ | 76 -42.4% YoY -24.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of ADMA Biologics news was 5.43 per week. The last year interest of ADMA Biologics news compared to the last 5 years has changed by 1.29%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 101.47%.
After 38 days of this quarter the interest is at 40.0. Based on that we can calculate that during remaining 53 days it will total up to 96.0. BIVIGAM expected interest is significantly lower compared to previous quarter (-48.4%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 108 | 78 -27.8% QoQ | 127 62.8% QoQ | 17 -86.6% QoQ |
| 2020 | 116 7.4% YoY 582.4% QoQ | 68 -12.8% YoY -41.4% QoQ | 217 70.9% YoY 219.1% QoQ | 64 276.5% YoY -70.5% QoQ |
| 2021 | 44 -62.1% YoY -31.2% QoQ | 211 210.3% YoY 379.5% QoQ | 178 -18.0% YoY -15.6% QoQ | 89 39.1% YoY -50.0% QoQ |
| 2022 | 74 68.2% YoY -16.9% QoQ | 115 -45.5% YoY 55.4% QoQ | 230 29.2% YoY 100.0% QoQ | 119 33.7% YoY -48.3% QoQ |
| 2023 | 132 78.4% YoY 10.9% QoQ | 252 119.1% YoY 90.9% QoQ | 167 -27.4% YoY -33.7% QoQ | 186 56.3% YoY 11.4% QoQ |
| 2024 | 40 -69.7% YoY -78.5% QoQ | - | - | - |
The average 5 years interest of BIVIGAM was 10.12 per week. The last year interest of BIVIGAM compared to the last 5 years has changed by 29.64%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 94.95%.
After 38 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 53 days it will total up to 0.0. ASCENIV expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 18 | 122 577.8% QoQ | 193 58.2% QoQ | 181 -6.2% QoQ |
| 2020 | 53 194.4% YoY -70.7% QoQ | 56 -54.1% YoY 5.7% QoQ | 70 -63.7% YoY 25.0% QoQ | 66 -63.5% YoY -5.7% QoQ |
| 2021 | 124 134.0% YoY 87.9% QoQ | 126 125.0% YoY 1.6% QoQ | 153 118.6% YoY 21.4% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 18 -85.5% YoY inf% QoQ | 49 -61.1% YoY 172.2% QoQ | 73 -52.3% YoY 49.0% QoQ | 31 inf% YoY -57.5% QoQ |
| 2023 | 160 788.9% YoY 416.1% QoQ | 178 263.3% YoY 11.2% QoQ | 91 24.7% YoY -48.9% QoQ | 150 383.9% YoY 64.8% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of ASCENIV was 7.35 per week. The last year interest of ASCENIV compared to the last 5 years has changed by 25.31%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -13.52%.
There is not enough data for Nabi-HB to provide analysis
There is not enough data for Nabi-HB to provide correlation calculation
There is not enough data for Nabi-HB to provide analysis
There is not enough data for ADMA Biologics address to provide analysis
There is not enough data for ADMA Biologics address to provide correlation calculation
There is not enough data for ADMA Biologics address to provide analysis
There is not enough data for ADMA Biologics phone number to provide analysis
There is not enough data for ADMA Biologics phone number to provide correlation calculation
There is not enough data for ADMA Biologics phone number to provide analysis
There is not enough data for plasma-derived biologics to provide analysis
There is not enough data for plasma-derived biologics to provide correlation calculation
There is not enough data for plasma-derived biologics to provide analysis
There is not enough data for immune deficiencies treatment to provide analysis
There is not enough data for immune deficiencies treatment to provide correlation calculation
There is not enough data for immune deficiencies treatment to provide analysis